Salix Pharmaceuticals (SLXP): Q4 EPS of $0.66 beats by $0.17. Revenue of $118.5M (+69% Y/Y)...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor
Salix Pharmaceuticals (SLXP): Q4 EPS of $0.66 beats by $0.17. Revenue of $118.5M (+69% Y/Y) in-line. (PR)